View in EDS HTML Full Text PDF Full Text

Evaluation of Bortezomib-BeEAM (2BeEAM) as Chemotherapy Regimen Prior to ASCT in Patients with Mantle Cell Lymphoma.

Saved in:
Bibliographic Details
Title: Evaluation of Bortezomib-BeEAM (2BeEAM) as Chemotherapy Regimen Prior to ASCT in Patients with Mantle Cell Lymphoma.
Authors: Huwyler, Fabrizio1 (AUTHOR), Kunz, Rebekka1 (AUTHOR), Bacher, Ulrike2 (AUTHOR), Hoffmann, Michèle1 (AUTHOR), Novak, Urban1 (AUTHOR), Daskalakis, Michael2 (AUTHOR), Banz, Yara3 (AUTHOR), Pabst, Thomas1 (AUTHOR) thomas.pabst@insel.ch
Source: Cancers. Apr2023, Vol. 15 Issue 7, p2091. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers15072091